Eva M. Briso

718 total citations
6 papers, 579 citations indexed

About

Eva M. Briso is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Eva M. Briso has authored 6 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Genetics, 3 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Eva M. Briso's work include Chronic Lymphocytic Leukemia Research (3 papers), Immunotherapy and Immune Responses (2 papers) and Immune Cell Function and Interaction (2 papers). Eva M. Briso is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Immunotherapy and Immune Responses (2 papers) and Immune Cell Function and Interaction (2 papers). Eva M. Briso collaborates with scholars based in United States, Spain and Italy. Eva M. Briso's co-authors include Mercedes Rincón, Oliver Dienz, Warren J. Leonard, Wendy Neveu, Colette Charland, Gennaro Ciliberto, Jeffrey P. Bond, Sheri M. Eaton, Laura Haynes and David Moquin and has published in prestigious journals such as The Journal of Experimental Medicine, Genes & Development and Blood.

In The Last Decade

Eva M. Briso

6 papers receiving 561 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eva M. Briso United States	6	330	149	114	65	59	6	579
Jesse L. Gurgel United States	5	429 1.3×	176 1.2×	97 0.9×	68 1.0×	106 1.8×	6	700
Gheorghe Hundorfean Germany	13	364 1.1×	281 1.9×	129 1.1×	147 2.3×	83 1.4×	24	787
Sébastien Lemoine France	11	448 1.4×	78 0.5×	58 0.5×	65 1.0×	52 0.9×	14	604
Vijay Kuchroo United States	7	520 1.6×	133 0.9×	95 0.8×	63 1.0×	29 0.5×	15	696
Rudolf Horváth Czechia	13	441 1.3×	165 1.1×	165 1.4×	49 0.8×	19 0.3×	27	652
Federico Serana Italy	16	376 1.1×	145 1.0×	84 0.7×	115 1.8×	141 2.4×	41	576
Carly E. Gregor Australia	8	421 1.3×	208 1.4×	121 1.1×	53 0.8×	42 0.7×	8	635
Bernice Lo United States	16	519 1.6×	125 0.8×	137 1.2×	84 1.3×	33 0.6×	30	796
Federica Capolunghi Italy	9	425 1.3×	50 0.3×	125 1.1×	65 1.0×	34 0.6×	10	645
Ursula Holzer Germany	17	366 1.1×	125 0.8×	183 1.6×	86 1.3×	40 0.7×	45	729

Countries citing papers authored by Eva M. Briso

Since Specialization

Citations

This map shows the geographic impact of Eva M. Briso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva M. Briso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva M. Briso more than expected).

Fields of papers citing papers by Eva M. Briso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva M. Briso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva M. Briso. The network helps show where Eva M. Briso may publish in the future.

Co-authorship network of co-authors of Eva M. Briso

This figure shows the co-authorship network connecting the top 25 collaborators of Eva M. Briso. A scholar is included among the top collaborators of Eva M. Briso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva M. Briso. Eva M. Briso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Trotman, Judith, Christian Buske, Alessandra Tedeschi, et al.. (2021). Single-Agent Ibrutinib for Rituximab-Refractory Waldenström Macroglobulinemia: Final Analysis of the Substudy of the Phase III InnovateTM Trial. Clinical Cancer Research. 27(21). 5793–5800. 27 indexed citations

2.

Trotman, Judith, Christian Buske, Alessandra Tedeschi, et al.. (2020). Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial. Blood. 136(Supplement 1). 38–39. 5 indexed citations

3.

Hájek, Roman, Luděk Pour, Muhıt Özcan, et al.. (2019). A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma. European Journal Of Haematology. 104(5). 435–442. 12 indexed citations

4.

Briso, Eva M., Juan Guinea‐Viniegra, Latifa Bakiri, et al.. (2013). Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos. Genes & Development. 27(18). 1959–1973. 57 indexed citations

5.

Dienz, Oliver, Sheri M. Eaton, Jeffrey P. Bond, et al.. (2009). The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. The Journal of Experimental Medicine. 206(1). 69–78. 340 indexed citations

6.

Briso, Eva M., Oliver Dienz, & Mercedes Rincón. (2008). Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells. The Journal of Immunology. 180(11). 7102–7106. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact